Skip to main navigation

Search for:

Skip to content

Main Navigation

News & Media
Publications
Join Us
Contact
Blog
Search

About Us
Approach
Platform & Pipeline
Patients & Caregivers
Medical Professionals
Investors

News Releases

Year

February 16, 2023

First AML Patient Transplanted with Vor Bio’s Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level

Read More

January 19, 2023

Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings

Read More

January 12, 2023

Vor Bio to Present at B. Riley Securities’ 3rd Annual Oncology Conference

Read More

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 13 of 13

Shareholder Tools

Print Page

RSS

Email Alerts

Contact IR

Search

Follow us on social media:

Twitter LinkedIn

About Us
Approach
Platform & Pipeline
- Our Platform
- Our Pipeline
Patients & Caregivers
Medical Professionals
- Our Investigational Program
- Clinical Trials
Investors
News & Media
Publications
Join Us
Blog

© 2022 Vor Biopharma

Privacy Policy
Terms of Use